1.79

1.10% -0.02

After Hours: 1.79

Essa Pharma Inc (EPIX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Essa Pharma Inc stock is traded at $1.79, with a volume of 203.01K. It is down -1.10% in the last 24 hours and down -67.75% over the past month. ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

Previous Close:

$1.81

Open:

$1.79

24h Volume:

203.01K

Relative Volume:

0.26

Market Cap:

$81.67M

Revenue:

Net Income/Loss:

$-25.80M

P/E Ratio:

-2.8871

EPS:

-0.62

Net Cash Flow:

$-22.19M

1W Performance:

+3.47%

1M Performance:

-67.75%

6M Performance:

-71.99%

1Y Performance:

-69.66%

1-Day Range:

$1.7806

$1.85

1-Week Range:

$1.73

$1.87

52-Week Range:

$1.40

$11.67

Essa Pharma Inc Stock (EPIX) Company Profile

Name

Essa Pharma Inc

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

(778) 331-0962

Address

SUITE 720, VANCOUVER, BC

Employee

Twitter

@essapharma

Next Earnings Date

2024-08-06

Latest SEC Filings

EPIX's Discussions on Twitter

Compare EPIX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EPIX Essa Pharma Inc	1.79	81.67M	0	-25.80M	-22.19M	-0.62
VRTX Vertex Pharmaceuticals Inc	464.56	119.70B	10.63B	-479.80M	-1.35B	13.33
REGN Regeneron Pharmaceuticals Inc	754.87	82.75B	13.85B	4.65B	3.32B	35.06
ARGX Argen X Se Adr	614.59	36.73B	1.86B	-40.29M	-1.28B	-4.16
ALNY Alnylam Pharmaceuticals Inc	253.74	32.53B	2.09B	-332.26M	16.06M	-4.14
BNTX Biontech Se Adr	120.72	28.50B	3.30B	-501.07M	1.03B	11.54

Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-04-24	Downgrade	Jefferies	Buy → Hold
Nov-04-24	Downgrade	Oppenheimer	Outperform → Perform
Nov-04-24	Downgrade	Piper Sandler	Overweight → Neutral
Jun-26-23	Resumed	Oppenheimer	Outperform
Mar-04-21	Initiated	Piper Sandler	Overweight
Jan-11-21	Reiterated	H.C. Wainwright	Buy
Nov-02-20	Initiated	Jefferies	Buy
Oct-25-19	Initiated	Oppenheimer	Outperform

View All

Essa Pharma Inc Stock (EPIX) Latest News

Nov 25, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc.EPIX - PR Newswire

Nov 25, 2024

Nov 20, 2024

Piper Sandler Downgrades ESSA Pharma (EPIX) - MSN

Nov 20, 2024

United States shares higher at close of trade; Dow Jones Industrial Average up 0.69% - MSN

Nov 20, 2024

Thinking about buying stock in Adverum Biotechnologies, Roma Gre - GuruFocus.com

Nov 20, 2024

ESSA Pharma (NASDAQ:EPIX) Stock Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat

Nov 14, 2024

Nov 10, 2024

ESSA Pharma And 2 Other US Penny Stocks To Watch - Yahoo Finance

Nov 10, 2024

Nov 08, 2024

Jones Trading Downgrades ESSA Pharma (EPIX) - MSN

Nov 08, 2024

ESSA Pharma (NASDAQ:EPIX) Lowered to Market Perform Rating by Oppenheimer - Defense World

Nov 08, 2024

ESSA Pharma (NASDAQ:EPIX) Rating Lowered to Neutral at Piper Sandler - Defense World

Nov 08, 2024

Nov 06, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ESSA Pharma Inc. (EPIX) and Encourages Shareholders to Learn More About the Investigation - AccessWire

Nov 06, 2024

Nov 05, 2024

Finance Watch: Syndax Raises $350m, KalVista Gets $100m In Royalty Deals - Citeline News & Insights

Nov 05, 2024

Growth N. V. Biotech Sells 7,879,583 Shares of ESSA Pharma Inc. (NASDAQ:EPIX) Stock - MarketBeat

Nov 05, 2024

Bb biotech ag sells Essa Pharma shares for $12 million - Investing.com

Nov 05, 2024

Bb biotech ag sells Essa Pharma shares for $12 million By Investing.com - Investing.com UK

Nov 05, 2024